tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CALT Stock Latest News

Calliditas says partner initiated Phase III Nefecon trial in Japan
The FlyCalliditas says partner initiated Phase III Nefecon trial in Japan
18d ago
CALT
Calliditas Therapeutics announces USPTO issues patent for setanaxib
PremiumThe Fly
Calliditas Therapeutics announces USPTO issues patent for setanaxib
1M ago
CALT
Calliditas Therapeutics’ Annual Meeting Highlights
PremiumCompany Announcements
Calliditas Therapeutics’ Annual Meeting Highlights
1M ago
6K
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Pareto
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at Pareto
2M ago
CALT
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at SEB Equities
2M ago
CALT
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
PremiumThe FlyWynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
2M ago
O
BZH
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe Fly
Calliditas Therapeutics downgraded to Neutral from Buy at Citi
2M ago
CALT
CHMP Endorses Calliditas’ Kinpeygo for IgAN
PremiumCompany Announcements
CHMP Endorses Calliditas’ Kinpeygo for IgAN
2M ago
6K
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at Jefferies
2M ago
CALT
Calliditas Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Calliditas Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
CALT
Calliditas Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Calliditas Therapeutics downgraded to Hold from Buy at Stifel
2M ago
CALT
Calliditas Therapeutics presents data at European Renal Association Congress
PremiumThe Fly
Calliditas Therapeutics presents data at European Renal Association Congress
2M ago
CALT
M&A News: Asahi Kasei Offers to Acquire Calliditas in $1.1 Billion Deal
PremiumMarket NewsM&A News: Asahi Kasei Offers to Acquire Calliditas in $1.1 Billion Deal
2M ago
CALT
Calliditas Therapeutics board recommends shareholders accept Asahi offer
PremiumThe Fly
Calliditas Therapeutics board recommends shareholders accept Asahi offer
2M ago
CALT
Calliditas Therapeutics price target lowered to $45 from $50 at H.C. Wainwright
PremiumThe Fly
Calliditas Therapeutics price target lowered to $45 from $50 at H.C. Wainwright
2M ago
CALT
Calliditas Therapeutics Q1 2024 Financial Surge
PremiumCompany Announcements
Calliditas Therapeutics Q1 2024 Financial Surge
2M ago
6K
CALT
Calliditas Therapeutics price target raised to $58 from $57 at Jefferies
PremiumThe Fly
Calliditas Therapeutics price target raised to $58 from $57 at Jefferies
2M ago
CALT
Calliditas Therapeutics Ab (CALT) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Calliditas Therapeutics Ab (CALT) Q1 Earnings Cheat Sheet
2M ago
CALT
Calliditas Therapeutics Schedules 2024 AGM
PremiumCompany Announcements
Calliditas Therapeutics Schedules 2024 AGM
2M ago
6K
CALT
Calliditas Therapeutics: Everest Medicines launches Nefecon in China
PremiumThe FlyCalliditas Therapeutics: Everest Medicines launches Nefecon in China
2M ago
CALT
Calliditas Reports Breakthrough in Cancer Trial
PremiumCompany Announcements
Calliditas Reports Breakthrough in Cancer Trial
3M ago
6K
CALT
Calliditas setanaxib trial misses primary endpoint, meets secondary endpoints
PremiumThe Fly
Calliditas setanaxib trial misses primary endpoint, meets secondary endpoints
3M ago
CALT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >